National Institute of Health
Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute
Postdoctoral Fellow
Research field (3)：
Tumor diagnostics and therapeutics
, Tumor biology
, Obstetrics and gynecology
Research keywords (2)：
gynecologic malignancy
, Nf-kB
Papers (8)：
Anne M Noonan, Amanda Cousins, David Anderson, Kristen P Zeligs, Kristen Bunch, Lidia Hernandez, Yusuke Shibuya, Ian S Goldlust, Rajarshi Guha, Marc Ferrer, et al. Matrix Drug Screen Identifies Synergistic Drug Combinations to Augment SMAC Mimetic Activity in Ovarian Cancer. Cancers. 2020. 12. 12
Shoko Sakurada, Yoh Watanabe, Yusuke Shibuya, Hideki Tokunaga, Sakae Saito, Jun Yasuda, Hidekazu Yamada, Hitoshi Niikura, Nobuo Yaegashi. DNA Copy Number Alteration in Primary Fallopian Tube Carcinoma. REPRODUCTIVE SCIENCES. 2017. 24. 138A-138A
Junko Minato, Hideki Tokunaga, Satoshi Okamoto, Yusuke Shibuya, Hitoshi Niikura, Nobuo Yaegashi. Is Imprint Cytology Useful to Diagnose Malignancy for Brenner Tumors? A Case Series at a Single Institute. Acta cytologica. 2017. 61. 2. 153-159
卵巣明細胞癌の分子病態 次世代シーケンシングによる卵巣明細胞癌における体細胞遺伝的変化の同定(Molecular Pathogenesis of Ovarian Clear Cell Carcinoma Identification of somatic genetic alterations in ovarian clear cell carcinoma with next generation sequencing)
(日本婦人科腫瘍学会雑誌 2018)
卵巣明細胞癌における次世代配列分析による体細胞遺伝子変異の同定(Identification of somatic genetic alterations in ovarian clear cell carcinoma with next generation sequencing)
(日本産科婦人科学会雑誌 2018)
次世代シーケンシングによる卵巣明細胞癌における体細胞遺伝子変化の同定(Identification of somatic genetic alterations in ovarian clear cell carcinomas with next generation sequencing)
(The Journal of Obstetrics and Gynaecology Research 2017)
次世代シークエンシングを用いた卵巣明細胞癌における体細胞遺伝的変化の同定(Identification of somatic genetic alterations in ovarian clear cell carcinomas with next generation sequencing)
(日本産科婦人科学会雑誌 2017)
